Aldeyra Therapeutics, Inc.
ALDX
$4.91
$0.040.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 54.52% | -44.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.32% | -2.48% | |||
| Operating Income | 21.32% | 2.48% | |||
| Income Before Tax | 21.29% | 1.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.29% | 1.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.29% | 1.63% | |||
| EBIT | 21.32% | 2.48% | |||
| EBITDA | 21.46% | 2.51% | |||
| EPS Basic | 21.39% | 1.87% | |||
| Normalized Basic EPS | 21.44% | 1.83% | |||
| EPS Diluted | 21.39% | 1.87% | |||
| Normalized Diluted EPS | 21.44% | 1.83% | |||
| Average Basic Shares Outstanding | 0.14% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||